Clinical Trials

146 enrolled

Phase 2 Active not recruiting

Endometrial Neoplasms

NCT06317311 2025-07-25

RUBY-J

41 enrolled

Carcinoma, Endometrial Neoplasms

NCT04527900 2025-06-19

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Phase 2 Terminated

2 enrolled

Endometrial Neoplasms

NCT00513786 2025-03-28

Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma

38 enrolled 12 charts

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT06751277 2024-12-27

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

26 enrolled

Recurrence, Endometrial Neoplasms

NCT06522828 2024-10-21

A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients

Phase 2 Recruiting

80 enrolled

Endometrial Neoplasms

NCT06413992 2024-05-14

Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer

Phase 2 Recruiting

117 enrolled

Neoplasm Metastasis, Recurrence, Endometrial Neoplasms

NCT03189446 2024-03-08

Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer

39 enrolled 8 charts

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT06297811 2024-03-07

Myeloprotection With Trilaciclib in Pan-cancer Population

132 enrolled

BreastGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06066216 2024-01-23

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Phase 2 Not yet recruiting

45 enrolled

Endometrial Neoplasms

NCT03935256 2023-12-18

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

24 enrolled

Neoplasms, Endometrial Neoplasms

NCT03503786 2023-11-13

MITO END-3

125 enrolled

Endometrial Neoplasms

NCT02549209 2022-03-02

Pembro/Carbo/Taxol in Endometrial Cancer

46 enrolled 13 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT01523678 2019-07-10

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

108 enrolled

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Endocrine System Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Urogenital Neoplasms, Uterine Diseases, Endometrial Neoplasms

NCT00258362 2017-12-28

Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer

41 enrolled 10 charts

Endometrial Neoplasms

NCT00879359 2017-04-26

Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer

15 enrolled 8 charts

Endometrial Neoplasms

NCT00502203 2016-05-09

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

23 enrolled 5 charts

Uterine Neoplasms, Endometrial Neoplasms, Mixed Tumor, Mullerian

NCT00470067 2014-08-22

Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer

Phase 2 Terminated

9 enrolled 6 charts

Endometrial Neoplasms

NCT00003560 2014-01-06

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

40 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT01100359 2013-08-07

Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer

39 enrolled

Endometrial Neoplasms

NCT00006377 2013-06-18

Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer

Endometrial Neoplasms

NCT00003127 2012-06-14

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

57 enrolled

Endometrial Neoplasms

NCT00401635 2007-09-05

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

42 enrolled